Friday, 03 Apr 2020

You are here

NSAIDs May Impair Healing if Taken Nightly

A new study in Scientific Reports suggest that circadian rhythms play an important role in wound healing, and that nonsteroidal anti-inflammatory drugs (NSAIDs) may be disruptive if taken at night given primary healing that occurs in a body at night. 

NSAIDs provide analgesic and antiinflammatory benefits via prostaglandin inhibition, yet NSAIDs are also thought to inhibit postoperative healing of connective tissues via the same mechanisms. 

Circadian rhythms regulate genes. This is a molecular clock that modulates the immune response and the healing processes in connective tissues  According to this rhythm, most of wound healing mediators and connective tissue formation occurs during the resting phase, at night. Conversely, pain, inflammation and tissue resorption occur during the active period of the day. 

For instance, there is a daytime, cyclic increase in macrophage activity, leukocyte recruitment, and pro-inflammatory mediators (IL-1β, IL-6, IL-12) during which there is an increase in Tol-Like Receptors TLR9 and TLR4, leading to the upregulation of CCL2, CXCL1, CCL5, and subsequent leukocyte recruitment and potential tissue damage in injured or repairing sites. It is during this phase that NSAIDs may have their most beneficial effect.

By contrast, anti-inflammatory mediators and other growth or angiogenesis factors, such as the vascular endothelial growth factor (VEGF), peak during the resting phase. The authors postulated that taking NSAIDs during this phase would impair healing.

Using a a murine tibia fracture surgical model, reseearchers showed that NSAIDs are most effective in managing postoperative pain, healing and recovery when drug administration is limited to the active phase (daytime) of the circadian rhythm.

Limiting NSAID treatment to the active phase of the circadian rhythm resulted in overexpression of circadian clock genes, such as Period 2 (Per2) at the healing callus, and increased serum levels of anti-inflammatory cytokines interleukin-13 (IL-13), interleukin-4 (IL-4) and vascular endothelial growth factor.

By contrast, NSAID administration during the resting phase resulted in severe bone healing impairment.  NSAID administration during the daily activity period resulted in better postoperative healing and recovery in this murine bone surgery model.

NSAIDs can exert a strong anti-inflammatory effect when given in the morning or early afternoon.  It is ill-advised to take these in the evening or at bedtime, largely because of an enhanced risk for adverse effects such as indigestion, stomach ulcers, and acute kidney injury, but now for the potential to impair tisue repair.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

IN MICE, John. IN MICE. This model may not apply to humans at all.

More Like This

Universal Masking for COVID?

In early March 2020, there were widespread recommendations that wearing routine "surgical masks" by the public sector was not likely to be helpful or advisable. Now we are hearing of a 180 degree shift in thinking with the CDC, leading health officials and the current NEJM Perspective pointing to more widespread use of masks by healthcare workers and even by individuals in the public sector.

COVID Infection Run Down with Dr. Kevin Winthrop

Dr Kevin Winthrop answers COVID questions and advocates for "hit the pause button, lay low and exercise". We discuss the utility of baricitinib, losartan, COVID testing, Next Success and who to listen to.

Dr. Artie Kavanaugh - Don't Stop!

Drs. Cush and Kavanaugh discuss the downside of stopping hydroxychloroquine, DMARDs and biologics in lupus, RA and pregnancy.

Venom Peptide-Steroid Conjugate Effective in Collagen Induced Arthritis

Science Translational Medicine features a report from the Fred Hutchinson Cancer Research Center showing that a scopion venom peptide, coupled to steroid, can significantly reduce joint inflammation in a rat model of rheumatoid arthritis (RA).

ACR Releases Reproductive Health Guidelines for Rheumatic Diseases

Today, the American College of Rheumatology (ACR) published the 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. This is the first, evidence-based, clinical practice guideline related to the management of reproductive health issues for all patients with rheumatic diseases.